Journal article
Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study
Abstract
The prevalence of osteoporosis in men is higher than previously assumed; consequently, numerous therapies are being investigated to treat these patients. The Canadian Database of Osteoporosis and Osteopenia patients (CANDOO) was analyzed to examine changes in bone mineral density (BMD) in consecutively seen osteoporotic men administered alendronate, etidronate or no bone-active drugs (control) over 1 year. A total of 244 men attending six …
Authors
Olszynski WP; Davison KS; Ioannidis G; Brown JP; Hanley DA; Josse RG; Murray TM; Papaioannou A; Sebaldt RJ; Tenenhouse AM
Journal
Osteoporosis International, Vol. 17, No. 2, pp. 217–224
Publisher
Springer Nature
Publication Date
2 2006
DOI
10.1007/s00198-005-1965-6
ISSN
0937-941X